EDGAR·FLOW

Translational Development Acquisition Corp. — Form 10-Q

Filed November 16, 2026 · analyzed by the Periodic Agent
10-Q — Neutral significance 48/100
What the filing says
Translational Development Acquisition Corp. amended its promissory note with TDAC Partners LLC, increasing the maximum principal amount from $2,000,000 to $4,000,000, effective November 10, 2026. The note is unsecured, bears no interest, and matures upon completion of a business combination. The payee has waived all claims against the company's IPO trust account. The original note was dated August 8, 2025, and amounts previously drawn in excess of $2M are now ratified under the amended note.
Why this rating

$4M facility is ~2.3% of $177.7M market cap—modest relative to company size. Routine debt restructuring for SPAC with no interest or immediate repayment pressure, typical pre-merger financing.

View original filing on SEC.gov ↗ TDACW · stock on Yahoo Finance ↗

See more from November 16, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.